Cheng-Lung Hsu, Ph.D. - Publications

Affiliations: 
2004 University of Rochester, Rochester, NY 
Area:
Molecular Biology

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lin CY, Lee LY, Wang TH, Hsu CL, Tsai CL, Chao A, Lai CH. Palbociclib Promotes Dephosphorylation of NPM/B23 at Threonine 199 and Inhibits Endometrial Cancer Cell Growth. Cancers. 11. PMID 31330844 DOI: 10.3390/cancers11071025  0.36
2019 Chung AK, OuYang CN, Liu H, Chao M, Luo JD, Lee CY, Lu YJ, Chung IC, Chen LC, Wu SM, Tsang NM, Chang KP, Hsu CL, Li HP, Chang YS. Targeted sequencing of cancer-related genes in nasopharyngeal carcinoma identifies mutations in the TGF-β pathway. Cancer Medicine. PMID 31328403 DOI: 10.1002/cam4.2429  0.36
2018 Hsu CL, Lui KW, Chi LM, Kuo YC, Chao YK, Yeh CN, Lee LY, Huang Y, Lin TL, Huang MY, Lai YR, Yeh YM, Fan HC, Lin AC, Lu YJ, et al. Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma. Journal of Experimental & Clinical Cancer Research : Cr. 37: 233. PMID 30236142 DOI: 10.1186/s13046-018-0873-5  0.36
2018 Wu YY, Chang KP, Lin CY, Pai PC, Wang HM, Hsu CL, Liao CT, Yen TC, Fang TJ, Huang SF, Kang CJ, Fang KH, Lin WN, Wang YC, Hsin LJ, et al. Prognostic significance of combined pretreatment lymphocyte counts and body mass index in patients with head and neck cancer treated with radiation therapy. Cancer Medicine. PMID 29790672 DOI: 10.1002/cam4.1489  0.36
2018 Chan SC, Yeh CH, Yen TC, Ng SH, Chang JT, Lin CY, Yen-Ming T, Fan KH, Huang BS, Hsu CL, Chang KP, Wang HM, Liao CT. Clinical utility of simultaneous whole-bodyF-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29502310 DOI: 10.1007/s00259-018-3986-3  0.36
2017 Hsu CL, Liu JS, Lin TW, Chang YH, Kuo YC, Lin AC, Ting HJ, Pang ST, Lee LY, Ma WL, Lin CC, Wu WG. Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening. Oncotarget. 8: 69508-69519. PMID 29050220 DOI: 10.18632/oncotarget.17843  0.68
2017 Chou YC, Lin CY, Pai PC, Tseng CK, Hsieh CE, Chang KP, Hsu CL, Liao CT, Wang CC, Chin SC, Yen TC, Ho TY, Hong JH, Lei KF, Chang JT, et al. Dose-escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score-matched study. Cancer Medicine. PMID 28809463 DOI: 10.1002/cam4.1150  0.36
2017 Hsu CL, Liu JS, Lin TW, Chang YH, Kuo YC, Lin AC, Ting HJ, Pang ST, Lee LY, Ma WL, Lin CC, Wu WG. Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening. Oncotarget. PMID 28562322 DOI: 10.18632/oncotarget.17843  0.68
2016 Wang HM, Lin TL, Kuo YC, Li HP, Chang KP, Lin CY, Fan HC, Lin AC, Hsieh CH, Tsang NM, Lee LY, Chan SC, Lui KW, Chang YS, Hsu CL. Correlation between overall survival and differential plasma and tissue tumor marker expression in nasopharyngeal carcinoma patients with different sites of organ metastasis. Oncotarget. PMID 27448966 DOI: 10.18632/oncotarget.10676  0.6
2016 Chan SC, Chang KP, Fang YD, Tsang NM, Ng SH, Hsu CL, Liao CT, Yen TC. Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma. The Laryngoscope. PMID 27435352 DOI: 10.1002/lary.26172  0.6
2016 Lai HC, Yeh CC, Jeng LB, Huang SF, Liao PY, Lei FJ, Cheng WC, Hsu CL, Cai X, Chang C, Ma WL. Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells. Oncotarget. PMID 27340775 DOI: 10.18632/oncotarget.10186  0.6
2016 Wang HM, Lin CY, Hsieh CH, Hsu CL, Fan KH, Chang JT, Huang SF, Kang CJ, Liao CT, Ng SH, Yen TC. Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 27133181 DOI: 10.1016/j.jfma.2016.03.005  0.6
2016 Chin SC, Lin CY, Huang BS, Tsang NM, Fan KH, Ku YK, Hsu CL, Chan SC, Huang SF, Li CH, Tseng HJ, Liao CT, Liu HL, Sung K. Pretreatment Dynamic Contrast-Enhanced MRI Improves Prediction of Early Distant Metastases in Patients With Nasopharyngeal Carcinoma. Medicine. 95: e2567. PMID 26871776 DOI: 10.1097/MD.0000000000002567  0.36
2016 Dong YH, Chang CH, Gagne JJ, Hsu CL, Lai MS. Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study. Pharmacotherapy. 36: 26-37. PMID 26799347 DOI: 10.1002/phar.1684  0.32
2015 Adel M, Kao HK, Hsu CL, Huang JJ, Lee LY, Huang Y, Browne T, Tsang NM, Chang YL, Chang KP. Evaluation of Lymphatic and Vascular Invasion in Relation to Clinicopathological Factors and Treatment Outcome in Oral Cavity Squamous Cell Carcinoma. Medicine. 94: e1510. PMID 26512553 DOI: 10.1097/MD.0000000000001510  0.36
2015 Hsu CL, Kuo YC, Huang Y, Huang YC, Lui KW, Chang KP, Lin TL, Fan HC, Lin AC, Hsieh CH, Lee LY, Wang HM, Li HP, Chang YS. Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma. Oncotarget. PMID 26416517  0.36
2015 Dong YH, Hsu CL, Li YY, Chang CH, Lai MS. Bronchodilators use in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease. 10: 1769-79. PMID 26366069 DOI: 10.2147/COPD.S86198  0.32
2015 Liao CT, Fan KH, Kang CJ, Lin CY, Chang JT, Tsang NM, Huang BS, Chao YK, Lee LY, Hsueh C, Wang HM, Liau CT, Hsu CL, Hsieh CH, Ng SH, et al. Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies. Plos One. 10: e0136918. PMID 26335067 DOI: 10.1371/journal.pone.0136918  0.36
2015 Hsieh JC, Hsu CL, Ng SH, Wang CH, Lee K, Lu CH, Chang YF, Hsieh RK, Yeh KH, Hsiao CH, Chen SY, Shiau CY, Wang HM. Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: a multicenter prospective Phase II trial. Japanese Journal of Clinical Oncology. PMID 26056323 DOI: 10.1093/jjco/hyv083  0.6
2015 Lin YT, Chen JS, Wu MH, Hsieh IS, Liang CH, Hsu CL, Hong TM, Chen YL. Galectin-1 accelerates wound healing by regulating the neuropilin-1/Smad3/NOX4 pathway and ROS production in myofibroblasts. The Journal of Investigative Dermatology. 135: 258-68. PMID 25007042 DOI: 10.1038/jid.2014.288  0.6
2014 Hsu CL, Liu JS, Wu PL, Guan HH, Chen YL, Lin AC, Ting HJ, Pang ST, Yeh SD, Ma WL, Chen CJ, Wu WG, Chang C. Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis. Molecular Oncology. 8: 1575-87. PMID 25091737 DOI: 10.1016/j.molonc.2014.06.009  0.6
2014 Wang HM, Hsu CL, Hsieh CH, Fan KH, Lin CY, Chang JT, Huang SF, Chen IH, Liao CT, Ng SK. Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx. Biomedical Journal. 37: 133-40. PMID 24923571 DOI: 10.4103/2319-4170.117893  0.36
2014 Hsu CL, Liu JS, Lin AC, Yang CH, Chung WH, Wu WG. Minoxidil may suppress androgen receptor-related functions. Oncotarget. 5: 2187-97. PMID 24742982  0.6
2014 Yeh CT, Liang KH, Lin CC, Chang ML, Hsu CL, Hung CF. A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma. International Journal of Cancer. Journal International Du Cancer. 134: 1214-24. PMID 23959947 DOI: 10.1002/ijc.28439  0.6
2013 Hsin LJ, Kao HK, Chen IH, Tsang NM, Hsu CL, Liu SC, Chang YS, Chang KP. Serum CXCL9 levels are associated with tumor progression and treatment outcome in patients with nasopharyngeal carcinoma. Plos One. 8: e80052. PMID 24278236 DOI: 10.1371/journal.pone.0080052  0.6
2013 Li HP, Peng CC, Chung IC, Huang MY, Huang ST, Chen CC, Chang KP, Hsu CL, Chang YS. Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma. Oncotarget. 4: 2154-65. PMID 24243817 DOI: 10.18632/oncotarget.1367  0.36
2013 Hsieh CH, Hsu CL, Wang CH, Liaw CC, Chen JS, Chang HK, Yang TS, Chang JW, Lin YC, Liau CT, Tsang NM, Chang JT, Ng SH, Wang HM. Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma. Biomedical Journal. 36: 229-36. PMID 24225189 DOI: 10.4103/2319-4170.113375  0.36
2013 Hsu HC, Liu YS, Tseng KC, Hsu CL, Liang Y, Yang TS, Chen JS, Tang RP, Chen SJ, Chen HC. Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer. International Journal of Colorectal Disease. 28: 1535-46. PMID 23784051 DOI: 10.1007/s00384-013-1721-x  0.32
2013 Chan SC, Kuo WH, Wang HM, Chang JT, Lin CY, Ng SH, Hsu CL, Chang KP, Liao CT, Lin YJ, Yen TC. Prognostic implications of post-therapy (18)F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. Annals of Nuclear Medicine. 27: 710-9. PMID 23715831 DOI: 10.1007/s12149-013-0736-2  0.36
2013 Hsu CL, Chang CH, Lin JW, Wu LC, Chuang LM, Lai MS. Histamine-2 receptor antagonists and risk of lung cancer in diabetic patients – an exploratory analysis. Pharmacoepidemiology and Drug Safety. 22: 632-40. PMID 23576472 DOI: 10.1002/pds.3441  0.32
2013 Hsu CL, Chan SC, Chang KP, Lin TL, Lin CY, Hsieh CH, Huang SF, Tsang NM, Lee LY, Ng SH, Wang HM. Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma. Oral Oncology. 49: 620-5. PMID 23466197 DOI: 10.1016/j.oraloncology.2013.02.006  0.36
2013 Chan SC, Hsu CL, Yen TC, Ng SH, Liao CT, Wang HM. The role of 18F-FDG PET/CT metabolic tumour volume in predicting survival in patients with metastatic nasopharyngeal carcinoma. Oral Oncology. 49: 71-8. PMID 22959277 DOI: 10.1016/j.oraloncology.2012.07.016  0.36
2012 Chan SC, Wang HM, Ng SH, Hsu CL, Lin YJ, Lin CY, Liao CT, Yen TC. Utility of 18F-fluoride PET/CT and 18F-FDG PET/CT in the detection of bony metastases in heightened-risk head and neck cancer patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1730-5. PMID 22961077 DOI: 10.2967/jnumed.112.104893  0.36
2012 Cheng NM, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Liao CT, Lin CY, Hsu CL, Yen TC. Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 39: 1673-84. PMID 22854984 DOI: 10.1007/s00259-012-2186-9  0.36
2012 Ma WL, Hsu CL, Yeh CC, Wu MH, Huang CK, Jeng LB, Hung YC, Lin TY, Yeh S, Chang C. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology (Baltimore, Md.). 56: 176-85. PMID 22318717 DOI: 10.1002/hep.25644  0.68
2012 Chang KP, Tsang NM, Liao CT, Hsu CL, Chung MJ, Lo CW, Chan SC, Ng SH, Wang HM, Yen TC. Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 21-8. PMID 22213820 DOI: 10.2967/jnumed.111.090696  0.36
2012 Hsu CL, Chang KP, Lin CY, Chang HK, Wang CH, Lin TL, Liao CT, Tsang NM, Lee LY, Chan SC, Ng SH, Li HP, Chang YS, Wang HM. Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma. Head & Neck. 34: 1064-70. PMID 22083949 DOI: 10.1002/hed.21890  0.36
2011 Chang KP, Chang YT, Wu CC, Liu YL, Chen MC, Tsang NM, Hsu CL, Chang YS, Yu JS. Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival. Head & Neck. 33: 886-97. PMID 21560180 DOI: 10.1002/hed.21557  0.6
2011 Yeh CT, Chen HC, Sung CM, Hsu CL, Lin CC, Pan KT, Tseng JH, Hung CF. Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma. Bmc Cancer. 11: 117. PMID 21453495 DOI: 10.1186/1471-2407-11-117  0.6
2011 Lee LY, Chang KP, Hsu CL, Chen TC, Kuo TT. Small-cell neuroendocrine carcinoma of the nasopharynx: report of a rare case lacking association with Epstein-Barr virus. International Journal of Surgical Pathology. 19: 199-202. PMID 18508843 DOI: 10.1177/1066896908316904  0.36
2010 Chen CY, Hsu CL, Chang CH, Chen KY, Yu CJ, Yang PC. Hemothorax in a medical intensive care unit: incidence, comorbidity and prognostic factors. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 109: 574-81. PMID 20708508 DOI: 10.1016/S0929-6646(10)60094-0  0.32
2010 Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, Ryan CK, Hung YC, Yeh S, Chang C. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Science Translational Medicine. 2: 32ra35. PMID 20484730 DOI: 10.1126/scitranslmed.3001143  0.68
2009 Hsu CL, Chang CH, Wong KN, Chen KY, Yu CJ, Yang PC. Management of severe community-acquired septic meningitis in adults: from emergency department to intensive care unit. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 108: 112-8. PMID 19251546 DOI: 10.1016/S0929-6646(09)60041-3  0.32
2009 Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, Liu FY, Chin SC, Fan KH, Hsu CL. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up. European Journal of Nuclear Medicine and Molecular Imaging. 36: 12-22. PMID 18704401 DOI: 10.1007/s00259-008-0918-7  0.6
2008 Ma WL, Ma CL, Hsu CL, Wu MH, Wu CT, Wu CC, Lai JJ, Jou YS, Chen CW, Yeh S, Chang C. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology. 135: 947-55, 955.e1-5. PMID 18639551 DOI: 10.1053/j.gastro.2008.05.046  0.68
2008 Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, Altuwaijri S, Hsu CL, Ma WL, Jokinen J, Sparks JD, Yeh S, Chang C. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology (Baltimore, Md.). 47: 1924-35. PMID 18449947 DOI: 10.1002/hep.22252  0.6
2008 Cai Y, Lee YF, Li G, Liu S, Bao BY, Huang J, Hsu CL, Chang C. A new prostate cancer therapeutic approach: combination of androgen ablation with COX-2 inhibitor. International Journal of Cancer. 123: 195-201. PMID 18386814 DOI: 10.1002/ijc.23481  0.68
2008 Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma. Oral Oncology. 44: 784-92. PMID 18206420 DOI: 10.1016/j.oraloncology.2007.10.003  0.36
2007 Wu CT, Chen WC, Liao SK, Hsu CL, Lee KD, Chen MF. The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy. Endocrine-Related Cancer. 14: 633-43. PMID 17914094 DOI: 10.1677/ERC-07-0073  0.36
2007 Juang SH, Lung CC, Hsu PC, Hsu KS, Li YC, Hong PC, Shiah HS, Kuo CC, Huang CW, Wang YC, Huang L, Chen TS, Chen SF, Fu KC, Hsu CL, et al. D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation. Molecular Cancer Therapeutics. 6: 193-202. PMID 17237279 DOI: 10.1158/1535-7163.MCT-06-0482  0.4
2006 Chan SC, Ng SH, Chang JT, Lin CY, Chen YC, Chang YC, Hsu CL, Wang HM, Liao CT, Yen TC. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging. European Journal of Nuclear Medicine and Molecular Imaging. 33: 1032-40. PMID 16622711 DOI: 10.1007/s00259-005-0054-6  0.36
2005 Ting HJ, Bao BY, Hsu CL, Lee YF. Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity. Endocrine. 26: 1-9. PMID 15805579 DOI: 10.1385/ENDO:26:1:001  0.68
2005 Hsu CL, Chen KY, Chang CH, Jerng JS, Yu CJ, Yang PC. Timing of tracheostomy as a determinant of weaning success in critically ill patients: a retrospective study. Critical Care (London, England). 9: R46-52. PMID 15693966 DOI: 10.1186/cc3018  0.32
2005 Hsu CL, Chen YL, Ting HJ, Lin WJ, Yang Z, Zhang Y, Wang L, Wu CT, Chang HC, Yeh S, Pimplikar SW, Chang C. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. Molecular Endocrinology (Baltimore, Md.). 19: 350-61. PMID 15514032 DOI: 10.1210/me.2004-0190  0.68
2005 Wang L, Hsu CL, Chang C. Androgen receptor corepressors: an overview. The Prostate. 63: 117-30. PMID 15486994 DOI: 10.1002/pros.20170  0.6
2004 Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C. Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. The Journal of Biological Chemistry. 279: 33438-46. PMID 15166229 DOI: 10.1074/jbc.M401781200  0.68
2004 Wang L, Hsu CL, Ni J, Wang PH, Yeh S, Keng P, Chang C. Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells. Molecular and Cellular Biology. 24: 2202-13. PMID 14966297  0.68
2003 Hsu CL, Chen YL, Yeh S, Ting HJ, Hu YC, Lin H, Wang X, Chang C. The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs. The Journal of Biological Chemistry. 278: 23691-8. PMID 12714604 DOI: 10.1074/jbc.M211908200  0.68
2002 Wang X, Yang Y, Guo X, Sampson ER, Hsu CL, Tsai MY, Yeh S, Wu G, Guo Y, Chang C. Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator. The Journal of Biological Chemistry. 277: 15426-31. PMID 11856738 DOI: 10.1074/jbc.M111218200  0.68
2001 Wang X, Yeh S, Wu G, Hsu CL, Wang L, Chiang T, Yang Y, Guo Y, Chang C. Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells. The Journal of Biological Chemistry. 276: 40417-23. PMID 11509567 DOI: 10.1074/jbc.M104765200  0.68
2000 Yeh S, Sampson ER, Lee DK, Kim E, Hsu CL, Chen YL, Chang HC, Altuwaijri S, Huang KE, Chang C. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 99: 885-94. PMID 11155740  0.68
2000 Yeh S, Hu YC, Rahman M, Lin HK, Hsu CL, Ting HJ, Kang HY, Chang C. Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 97: 11256-61. PMID 11016951 DOI: 10.1073/pnas.190353897  0.68
Show low-probability matches.